Global Similar Biological Medicinal Products Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Similar Biological Medicinal Products Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

According to APO Research, The global Similar Biological Medicinal Products market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Similar Biological Medicinal Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Similar Biological Medicinal Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Similar Biological Medicinal Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Similar Biological Medicinal Products include CITIC Guojian, Changchun High-tech, Innovent Biologics, Saijin Biotechnology, Fuhong Hanlin, Baitai Biology, Biotech, Sandoz and Samsung Bioepies Co., Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Similar Biological Medicinal Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Similar Biological Medicinal Products.

The Similar Biological Medicinal Products market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Similar Biological Medicinal Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

CITIC Guojian
Changchun High-tech
Innovent Biologics
Saijin Biotechnology
Fuhong Hanlin
Baitai Biology
Biotech
Sandoz
Samsung Bioepies Co., Ltd
Amgen
Celltrion Healthcare
Coherus Biosciences, Inc.
Eli Lilly
Novartis AG
Pfizer Inc
Stada Arzneimittel AG
Teva Pharmaceutical Industries Ltd
Viatris

Similar Biological Medicinal Products segment by Type

Monoclonal Antibodies
Anti-inflammatory Drugs
Immunomodulator
Recombinant Hormone
Others

Similar Biological Medicinal Products segment by Application

Oncology
Blood Disorders
Growth Hormone Deficiency
Chronic and Autoimmune Diseases
Others

Similar Biological Medicinal Products Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Similar Biological Medicinal Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Similar Biological Medicinal Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Similar Biological Medicinal Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Similar Biological Medicinal Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Similar Biological Medicinal Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Similar Biological Medicinal Products Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Similar Biological Medicinal Products Sales Estimates and Forecasts (2019-2030)
1.3 Similar Biological Medicinal Products Market by Type
1.3.1 Monoclonal Antibodies
1.3.2 Anti-inflammatory Drugs
1.3.3 Immunomodulator
1.3.4 Recombinant Hormone
1.3.5 Others
1.4 Global Similar Biological Medicinal Products Market Size by Type
1.4.1 Global Similar Biological Medicinal Products Market Size Overview by Type (2019-2030)
1.4.2 Global Similar Biological Medicinal Products Historic Market Size Review by Type (2019-2024)
1.4.3 Global Similar Biological Medicinal Products Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Similar Biological Medicinal Products Sales Breakdown by Type (2019-2024)
1.5.2 Europe Similar Biological Medicinal Products Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Similar Biological Medicinal Products Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Similar Biological Medicinal Products Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Similar Biological Medicinal Products Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Similar Biological Medicinal Products Industry Trends
2.2 Similar Biological Medicinal Products Industry Drivers
2.3 Similar Biological Medicinal Products Industry Opportunities and Challenges
2.4 Similar Biological Medicinal Products Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Similar Biological Medicinal Products Revenue (2019-2024)
3.2 Global Top Players by Similar Biological Medicinal Products Sales (2019-2024)
3.3 Global Top Players by Similar Biological Medicinal Products Price (2019-2024)
3.4 Global Similar Biological Medicinal Products Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Similar Biological Medicinal Products Key Company Manufacturing Sites & Headquarters
3.6 Global Similar Biological Medicinal Products Company, Product Type & Application
3.7 Global Similar Biological Medicinal Products Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Similar Biological Medicinal Products Market CR5 and HHI
3.8.2 Global Top 5 and 10 Similar Biological Medicinal Products Players Market Share by Revenue in 2023
3.8.3 2023 Similar Biological Medicinal Products Tier 1, Tier 2, and Tier 3
4 Similar Biological Medicinal Products Regional Status and Outlook
4.1 Global Similar Biological Medicinal Products Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Similar Biological Medicinal Products Historic Market Size by Region
4.2.1 Global Similar Biological Medicinal Products Sales in Volume by Region (2019-2024)
4.2.2 Global Similar Biological Medicinal Products Sales in Value by Region (2019-2024)
4.2.3 Global Similar Biological Medicinal Products Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Similar Biological Medicinal Products Forecasted Market Size by Region
4.3.1 Global Similar Biological Medicinal Products Sales in Volume by Region (2025-2030)
4.3.2 Global Similar Biological Medicinal Products Sales in Value by Region (2025-2030)
4.3.3 Global Similar Biological Medicinal Products Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Similar Biological Medicinal Products by Application
5.1 Similar Biological Medicinal Products Market by Application
5.1.1 Oncology
5.1.2 Blood Disorders
5.1.3 Growth Hormone Deficiency
5.1.4 Chronic and Autoimmune Diseases
5.1.5 Others
5.2 Global Similar Biological Medicinal Products Market Size by Application
5.2.1 Global Similar Biological Medicinal Products Market Size Overview by Application (2019-2030)
5.2.2 Global Similar Biological Medicinal Products Historic Market Size Review by Application (2019-2024)
5.2.3 Global Similar Biological Medicinal Products Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Similar Biological Medicinal Products Sales Breakdown by Application (2019-2024)
5.3.2 Europe Similar Biological Medicinal Products Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Similar Biological Medicinal Products Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Similar Biological Medicinal Products Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Similar Biological Medicinal Products Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 CITIC Guojian
6.1.1 CITIC Guojian Comapny Information
6.1.2 CITIC Guojian Business Overview
6.1.3 CITIC Guojian Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CITIC Guojian Similar Biological Medicinal Products Product Portfolio
6.1.5 CITIC Guojian Recent Developments
6.2 Changchun High-tech
6.2.1 Changchun High-tech Comapny Information
6.2.2 Changchun High-tech Business Overview
6.2.3 Changchun High-tech Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Changchun High-tech Similar Biological Medicinal Products Product Portfolio
6.2.5 Changchun High-tech Recent Developments
6.3 Innovent Biologics
6.3.1 Innovent Biologics Comapny Information
6.3.2 Innovent Biologics Business Overview
6.3.3 Innovent Biologics Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Innovent Biologics Similar Biological Medicinal Products Product Portfolio
6.3.5 Innovent Biologics Recent Developments
6.4 Saijin Biotechnology
6.4.1 Saijin Biotechnology Comapny Information
6.4.2 Saijin Biotechnology Business Overview
6.4.3 Saijin Biotechnology Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Saijin Biotechnology Similar Biological Medicinal Products Product Portfolio
6.4.5 Saijin Biotechnology Recent Developments
6.5 Fuhong Hanlin
6.5.1 Fuhong Hanlin Comapny Information
6.5.2 Fuhong Hanlin Business Overview
6.5.3 Fuhong Hanlin Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Fuhong Hanlin Similar Biological Medicinal Products Product Portfolio
6.5.5 Fuhong Hanlin Recent Developments
6.6 Baitai Biology
6.6.1 Baitai Biology Comapny Information
6.6.2 Baitai Biology Business Overview
6.6.3 Baitai Biology Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Baitai Biology Similar Biological Medicinal Products Product Portfolio
6.6.5 Baitai Biology Recent Developments
6.7 Biotech
6.7.1 Biotech Comapny Information
6.7.2 Biotech Business Overview
6.7.3 Biotech Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Biotech Similar Biological Medicinal Products Product Portfolio
6.7.5 Biotech Recent Developments
6.8 Sandoz
6.8.1 Sandoz Comapny Information
6.8.2 Sandoz Business Overview
6.8.3 Sandoz Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sandoz Similar Biological Medicinal Products Product Portfolio
6.8.5 Sandoz Recent Developments
6.9 Samsung Bioepies Co., Ltd
6.9.1 Samsung Bioepies Co., Ltd Comapny Information
6.9.2 Samsung Bioepies Co., Ltd Business Overview
6.9.3 Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Product Portfolio
6.9.5 Samsung Bioepies Co., Ltd Recent Developments
6.10 Amgen
6.10.1 Amgen Comapny Information
6.10.2 Amgen Business Overview
6.10.3 Amgen Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Amgen Similar Biological Medicinal Products Product Portfolio
6.10.5 Amgen Recent Developments
6.11 Celltrion Healthcare
6.11.1 Celltrion Healthcare Comapny Information
6.11.2 Celltrion Healthcare Business Overview
6.11.3 Celltrion Healthcare Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Celltrion Healthcare Similar Biological Medicinal Products Product Portfolio
6.11.5 Celltrion Healthcare Recent Developments
6.12 Coherus Biosciences, Inc.
6.12.1 Coherus Biosciences, Inc. Comapny Information
6.12.2 Coherus Biosciences, Inc. Business Overview
6.12.3 Coherus Biosciences, Inc. Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Coherus Biosciences, Inc. Similar Biological Medicinal Products Product Portfolio
6.12.5 Coherus Biosciences, Inc. Recent Developments
6.13 Eli Lilly
6.13.1 Eli Lilly Comapny Information
6.13.2 Eli Lilly Business Overview
6.13.3 Eli Lilly Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Eli Lilly Similar Biological Medicinal Products Product Portfolio
6.13.5 Eli Lilly Recent Developments
6.14 Novartis AG
6.14.1 Novartis AG Comapny Information
6.14.2 Novartis AG Business Overview
6.14.3 Novartis AG Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Novartis AG Similar Biological Medicinal Products Product Portfolio
6.14.5 Novartis AG Recent Developments
6.15 Pfizer Inc
6.15.1 Pfizer Inc Comapny Information
6.15.2 Pfizer Inc Business Overview
6.15.3 Pfizer Inc Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Pfizer Inc Similar Biological Medicinal Products Product Portfolio
6.15.5 Pfizer Inc Recent Developments
6.16 Stada Arzneimittel AG
6.16.1 Stada Arzneimittel AG Comapny Information
6.16.2 Stada Arzneimittel AG Business Overview
6.16.3 Stada Arzneimittel AG Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Stada Arzneimittel AG Similar Biological Medicinal Products Product Portfolio
6.16.5 Stada Arzneimittel AG Recent Developments
6.17 Teva Pharmaceutical Industries Ltd
6.17.1 Teva Pharmaceutical Industries Ltd Comapny Information
6.17.2 Teva Pharmaceutical Industries Ltd Business Overview
6.17.3 Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Product Portfolio
6.17.5 Teva Pharmaceutical Industries Ltd Recent Developments
6.18 Viatris
6.18.1 Viatris Comapny Information
6.18.2 Viatris Business Overview
6.18.3 Viatris Similar Biological Medicinal Products Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Viatris Similar Biological Medicinal Products Product Portfolio
6.18.5 Viatris Recent Developments
7 North America by Country
7.1 North America Similar Biological Medicinal Products Sales by Country
7.1.1 North America Similar Biological Medicinal Products Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Similar Biological Medicinal Products Sales by Country (2019-2024)
7.1.3 North America Similar Biological Medicinal Products Sales Forecast by Country (2025-2030)
7.2 North America Similar Biological Medicinal Products Market Size by Country
7.2.1 North America Similar Biological Medicinal Products Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Similar Biological Medicinal Products Market Size by Country (2019-2024)
7.2.3 North America Similar Biological Medicinal Products Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Similar Biological Medicinal Products Sales by Country
8.1.1 Europe Similar Biological Medicinal Products Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Similar Biological Medicinal Products Sales by Country (2019-2024)
8.1.3 Europe Similar Biological Medicinal Products Sales Forecast by Country (2025-2030)
8.2 Europe Similar Biological Medicinal Products Market Size by Country
8.2.1 Europe Similar Biological Medicinal Products Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Similar Biological Medicinal Products Market Size by Country (2019-2024)
8.2.3 Europe Similar Biological Medicinal Products Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Similar Biological Medicinal Products Sales by Country
9.1.1 Asia-Pacific Similar Biological Medicinal Products Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Similar Biological Medicinal Products Sales by Country (2019-2024)
9.1.3 Asia-Pacific Similar Biological Medicinal Products Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Similar Biological Medicinal Products Market Size by Country
9.2.1 Asia-Pacific Similar Biological Medicinal Products Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Similar Biological Medicinal Products Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Similar Biological Medicinal Products Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Similar Biological Medicinal Products Sales by Country
10.1.1 Latin America Similar Biological Medicinal Products Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Similar Biological Medicinal Products Sales by Country (2019-2024)
10.1.3 Latin America Similar Biological Medicinal Products Sales Forecast by Country (2025-2030)
10.2 Latin America Similar Biological Medicinal Products Market Size by Country
10.2.1 Latin America Similar Biological Medicinal Products Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Similar Biological Medicinal Products Market Size by Country (2019-2024)
10.2.3 Latin America Similar Biological Medicinal Products Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Similar Biological Medicinal Products Sales by Country
11.1.1 Middle East and Africa Similar Biological Medicinal Products Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Similar Biological Medicinal Products Sales by Country (2019-2024)
11.1.3 Middle East and Africa Similar Biological Medicinal Products Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Similar Biological Medicinal Products Market Size by Country
11.2.1 Middle East and Africa Similar Biological Medicinal Products Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Similar Biological Medicinal Products Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Similar Biological Medicinal Products Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Similar Biological Medicinal Products Value Chain Analysis
12.1.1 Similar Biological Medicinal Products Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Similar Biological Medicinal Products Production Mode & Process
12.2 Similar Biological Medicinal Products Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Similar Biological Medicinal Products Distributors
12.2.3 Similar Biological Medicinal Products Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings